nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ORM1—Propranolol—migraine	0.142	0.185	CbGbCtD
Vemurafenib—ORM1—Amitriptyline—migraine	0.123	0.16	CbGbCtD
Vemurafenib—ABCC1—Verapamil—migraine	0.0887	0.116	CbGbCtD
Vemurafenib—ABCG2—Verapamil—migraine	0.0594	0.0774	CbGbCtD
Vemurafenib—ALB—Amitriptyline—migraine	0.0516	0.0673	CbGbCtD
Vemurafenib—CYP1A2—Propranolol—migraine	0.0357	0.0465	CbGbCtD
Vemurafenib—CYP2D6—Timolol—migraine	0.033	0.043	CbGbCtD
Vemurafenib—CYP1A2—Amitriptyline—migraine	0.0309	0.0402	CbGbCtD
Vemurafenib—CYP2D6—Propranolol—migraine	0.0294	0.0383	CbGbCtD
Vemurafenib—CYP1A2—Valproic Acid—migraine	0.0281	0.0367	CbGbCtD
Vemurafenib—CYP2D6—Amitriptyline—migraine	0.0254	0.0331	CbGbCtD
Vemurafenib—CYP1A2—Verapamil—migraine	0.0245	0.0319	CbGbCtD
Vemurafenib—CYP2D6—Verapamil—migraine	0.0202	0.0263	CbGbCtD
Vemurafenib—CYP3A4—Propranolol—migraine	0.0187	0.0244	CbGbCtD
Vemurafenib—CYP3A4—Amitriptyline—migraine	0.0162	0.0211	CbGbCtD
Vemurafenib—CYP3A4—Valproic Acid—migraine	0.0147	0.0192	CbGbCtD
Vemurafenib—CYP3A4—Topiramate—migraine	0.0133	0.0173	CbGbCtD
Vemurafenib—CYP3A4—Verapamil—migraine	0.0128	0.0167	CbGbCtD
Vemurafenib—RAF1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2B—migraine	0.00224	0.0377	CbGpPWpGaD
Vemurafenib—RAF1—Endothelin Pathways—CALCRL—migraine	0.00223	0.0374	CbGpPWpGaD
Vemurafenib—RAF1—Endothelin Pathways—RAMP1—migraine	0.00223	0.0374	CbGpPWpGaD
Vemurafenib—BRAF—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—migraine	0.00179	0.0301	CbGpPWpGaD
Vemurafenib—ALB—Scavenging of heme from plasma—LRP1—migraine	0.0015	0.0252	CbGpPWpGaD
Vemurafenib—Eosinophilia—Amitriptyline—migraine	0.00138	0.00799	CcSEcCtD
Vemurafenib—RAF1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2C—migraine	0.00136	0.0228	CbGpPWpGaD
Vemurafenib—RAF1—Stimuli-sensing channels—TRPM8—migraine	0.00132	0.0222	CbGpPWpGaD
Vemurafenib—BRAF—Ras signaling in the CD4+ TCR pathway—FOS—migraine	0.00128	0.0215	CbGpPWpGaD
Vemurafenib—Neuropathy peripheral—Amitriptyline—migraine	0.00122	0.00705	CcSEcCtD
Vemurafenib—Vasculitis—Valproic Acid—migraine	0.00121	0.007	CcSEcCtD
Vemurafenib—Gamma-glutamyltransferase increased—Gabapentin—migraine	0.00119	0.00688	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Propranolol—migraine	0.00119	0.00685	CcSEcCtD
Vemurafenib—BRAF—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.00111	0.0186	CbGpPWpGaD
Vemurafenib—Rash maculo-papular—Valproic Acid—migraine	0.00108	0.00621	CcSEcCtD
Vemurafenib—Neoplasm—Valproic Acid—migraine	0.00107	0.00618	CcSEcCtD
Vemurafenib—Infestation NOS—Propranolol—migraine	0.00102	0.00586	CcSEcCtD
Vemurafenib—Infestation—Propranolol—migraine	0.00102	0.00586	CcSEcCtD
Vemurafenib—Rigors—Topiramate—migraine	0.00101	0.00584	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Propranolol—migraine	0.00101	0.00581	CcSEcCtD
Vemurafenib—Gamma-glutamyltransferase increased—Topiramate—migraine	0.001	0.00579	CcSEcCtD
Vemurafenib—Alopecia—Amitriptyline—migraine	0.000989	0.00571	CcSEcCtD
Vemurafenib—Photosensitivity—Valproic Acid—migraine	0.000979	0.00565	CcSEcCtD
Vemurafenib—BRAF—Estrogen signaling pathway—ESR1—migraine	0.000957	0.0161	CbGpPWpGaD
Vemurafenib—Dysgeusia—Amitriptyline—migraine	0.000954	0.00551	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Verapamil—migraine	0.000926	0.00534	CcSEcCtD
Vemurafenib—BRAF—Neuronal System—KCNK18—migraine	0.000905	0.0152	CbGpPWpGaD
Vemurafenib—Rash maculo-papular—Gabapentin—migraine	0.000892	0.00515	CcSEcCtD
Vemurafenib—RAF1—Ras signaling in the CD4+ TCR pathway—FOS—migraine	0.000888	0.0149	CbGpPWpGaD
Vemurafenib—RAF1—Endothelin Pathways—EDNRA—migraine	0.000886	0.0149	CbGpPWpGaD
Vemurafenib—BRAF—Estrogen signaling pathway—FOS—migraine	0.000863	0.0145	CbGpPWpGaD
Vemurafenib—RAF1—Ion channel transport—TRPM8—migraine	0.000862	0.0145	CbGpPWpGaD
Vemurafenib—Erythema multiforme—Propranolol—migraine	0.000862	0.00497	CcSEcCtD
Vemurafenib—RAF1—Endothelin Pathways—CALCA—migraine	0.000853	0.0143	CbGpPWpGaD
Vemurafenib—Cardiac disorder—Propranolol—migraine	0.000846	0.00488	CcSEcCtD
Vemurafenib—Musculoskeletal pain—Topiramate—migraine	0.000836	0.00482	CcSEcCtD
Vemurafenib—RAF1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—migraine	0.000834	0.014	CbGpPWpGaD
Vemurafenib—Oedema peripheral—Verapamil—migraine	0.000826	0.00477	CcSEcCtD
Vemurafenib—Alopecia—Propranolol—migraine	0.000805	0.00465	CcSEcCtD
Vemurafenib—Erythema—Propranolol—migraine	0.000793	0.00458	CcSEcCtD
Vemurafenib—Erythema multiforme—Verapamil—migraine	0.000793	0.00458	CcSEcCtD
Vemurafenib—Dry skin—Valproic Acid—migraine	0.000788	0.00455	CcSEcCtD
Vemurafenib—RAF1—FSH signaling pathway—BDNF—migraine	0.000777	0.013	CbGpPWpGaD
Vemurafenib—Toxic epidermal necrolysis—Valproic Acid—migraine	0.000774	0.00447	CcSEcCtD
Vemurafenib—RAF1—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.000766	0.0129	CbGpPWpGaD
Vemurafenib—Pain in extremity—Timolol—migraine	0.000765	0.00442	CcSEcCtD
Vemurafenib—Atrial fibrillation—Gabapentin—migraine	0.000752	0.00434	CcSEcCtD
Vemurafenib—Rash maculo-papular—Topiramate—migraine	0.00075	0.00433	CcSEcCtD
Vemurafenib—Neoplasm—Topiramate—migraine	0.000747	0.00431	CcSEcCtD
Vemurafenib—Hypotension—Amitriptyline—migraine	0.000743	0.00429	CcSEcCtD
Vemurafenib—RAF1—Extracellular vesicle-mediated signaling in recipient cells—TGFBR2—migraine	0.000742	0.0124	CbGpPWpGaD
Vemurafenib—Alopecia—Verapamil—migraine	0.000741	0.00428	CcSEcCtD
Vemurafenib—Eosinophilia—Valproic Acid—migraine	0.000735	0.00424	CcSEcCtD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000735	0.0123	CbGpPWpGaD
Vemurafenib—Arthritis—Gabapentin—migraine	0.000733	0.00423	CcSEcCtD
Vemurafenib—Pain in extremity—Gabapentin—migraine	0.000712	0.00411	CcSEcCtD
Vemurafenib—Cough—Propranolol—migraine	0.000692	0.004	CcSEcCtD
Vemurafenib—Decreased appetite—Amitriptyline—migraine	0.000691	0.00399	CcSEcCtD
Vemurafenib—Fatigue—Amitriptyline—migraine	0.000686	0.00396	CcSEcCtD
Vemurafenib—Constipation—Amitriptyline—migraine	0.00068	0.00393	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Valproic Acid—migraine	0.000678	0.00391	CcSEcCtD
Vemurafenib—Weight decreased—Valproic Acid—migraine	0.000672	0.00388	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000671	0.00387	CcSEcCtD
Vemurafenib—BRAF—PDGFR-beta signaling pathway—LRP1—migraine	0.000659	0.0111	CbGpPWpGaD
Vemurafenib—Stevens-Johnson syndrome—Valproic Acid—migraine	0.000657	0.00379	CcSEcCtD
Vemurafenib—RAF1—Ion channel transport—ATP1A2—migraine	0.000653	0.011	CbGpPWpGaD
Vemurafenib—RAF1—Ion channel transport—ATP1A3—migraine	0.000653	0.011	CbGpPWpGaD
Vemurafenib—Dry skin—Gabapentin—migraine	0.000653	0.00377	CcSEcCtD
Vemurafenib—Anaphylactic shock—Propranolol—migraine	0.000648	0.00374	CcSEcCtD
Vemurafenib—Infection—Propranolol—migraine	0.000643	0.00371	CcSEcCtD
Vemurafenib—Nervous system disorder—Propranolol—migraine	0.000635	0.00367	CcSEcCtD
Vemurafenib—BRAF—Trk receptor signaling mediated by the MAPK pathway—FOS—migraine	0.000631	0.0106	CbGpPWpGaD
Vemurafenib—Skin disorder—Propranolol—migraine	0.000629	0.00363	CcSEcCtD
Vemurafenib—Body temperature increased—Amitriptyline—migraine	0.000629	0.00363	CcSEcCtD
Vemurafenib—RAF1—Neuronal System—KCNK18—migraine	0.000626	0.0105	CbGpPWpGaD
Vemurafenib—Arthralgia—Verapamil—migraine	0.000621	0.00359	CcSEcCtD
Vemurafenib—Myalgia—Verapamil—migraine	0.000621	0.00359	CcSEcCtD
Vemurafenib—Eosinophilia—Gabapentin—migraine	0.00061	0.00352	CcSEcCtD
Vemurafenib—Pain in extremity—Topiramate—migraine	0.000599	0.00346	CcSEcCtD
Vemurafenib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—LRP1—migraine	0.000599	0.01	CbGpPWpGaD
Vemurafenib—Weight decreased—Timolol—migraine	0.000598	0.00345	CcSEcCtD
Vemurafenib—Anaphylactic shock—Verapamil—migraine	0.000596	0.00344	CcSEcCtD
Vemurafenib—Infection—Verapamil—migraine	0.000592	0.00342	CcSEcCtD
Vemurafenib—Oedema peripheral—Valproic Acid—migraine	0.000586	0.00338	CcSEcCtD
Vemurafenib—Connective tissue disorder—Valproic Acid—migraine	0.000584	0.00337	CcSEcCtD
Vemurafenib—BRAF—Transmission across Chemical Synapses—CACNA1A—migraine	0.000577	0.00968	CbGpPWpGaD
Vemurafenib—Asthenia—Amitriptyline—migraine	0.000571	0.00329	CcSEcCtD
Vemurafenib—Decreased appetite—Propranolol—migraine	0.000563	0.00325	CcSEcCtD
Vemurafenib—Pruritus—Amitriptyline—migraine	0.000563	0.00325	CcSEcCtD
Vemurafenib—Erythema multiforme—Valproic Acid—migraine	0.000562	0.00324	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Gabapentin—migraine	0.000562	0.00324	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Propranolol—migraine	0.000559	0.00323	CcSEcCtD
Vemurafenib—Fatigue—Propranolol—migraine	0.000558	0.00322	CcSEcCtD
Vemurafenib—Weight decreased—Gabapentin—migraine	0.000557	0.00322	CcSEcCtD
Vemurafenib—Hypotension—Verapamil—migraine	0.000557	0.00321	CcSEcCtD
Vemurafenib—RAF1—Ion channel transport—HTR3A—migraine	0.000556	0.00932	CbGpPWpGaD
Vemurafenib—Eye disorder—Valproic Acid—migraine	0.000556	0.00321	CcSEcCtD
Vemurafenib—Constipation—Propranolol—migraine	0.000554	0.0032	CcSEcCtD
Vemurafenib—Infestation—Gabapentin—migraine	0.000549	0.00317	CcSEcCtD
Vemurafenib—Infestation NOS—Gabapentin—migraine	0.000549	0.00317	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Gabapentin—migraine	0.000544	0.00314	CcSEcCtD
Vemurafenib—Diarrhoea—Amitriptyline—migraine	0.000544	0.00314	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Verapamil—migraine	0.000543	0.00313	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Topiramate—migraine	0.00054	0.00311	CcSEcCtD
Vemurafenib—Angiopathy—Valproic Acid—migraine	0.000539	0.00311	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Gabapentin—migraine	0.000538	0.00311	CcSEcCtD
Vemurafenib—Mediastinal disorder—Valproic Acid—migraine	0.000536	0.00309	CcSEcCtD
Vemurafenib—Chills—Valproic Acid—migraine	0.000533	0.00308	CcSEcCtD
Vemurafenib—RAF1—Endothelins—EDNRA—migraine	0.000528	0.00886	CbGpPWpGaD
Vemurafenib—Dizziness—Amitriptyline—migraine	0.000526	0.00304	CcSEcCtD
Vemurafenib—Alopecia—Valproic Acid—migraine	0.000525	0.00303	CcSEcCtD
Vemurafenib—Oedema peripheral—Timolol—migraine	0.000521	0.00301	CcSEcCtD
Vemurafenib—Connective tissue disorder—Timolol—migraine	0.00052	0.003	CcSEcCtD
Vemurafenib—Malnutrition—Valproic Acid—migraine	0.000518	0.00299	CcSEcCtD
Vemurafenib—Fatigue—Verapamil—migraine	0.000514	0.00296	CcSEcCtD
Vemurafenib—Eosinophilia—Topiramate—migraine	0.000513	0.00296	CcSEcCtD
Vemurafenib—Body temperature increased—Propranolol—migraine	0.000512	0.00295	CcSEcCtD
Vemurafenib—Constipation—Verapamil—migraine	0.000509	0.00294	CcSEcCtD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000508	0.00853	CbGpPWpGaD
Vemurafenib—Dysgeusia—Valproic Acid—migraine	0.000507	0.00292	CcSEcCtD
Vemurafenib—Vomiting—Amitriptyline—migraine	0.000506	0.00292	CcSEcCtD
Vemurafenib—Rash—Amitriptyline—migraine	0.000501	0.00289	CcSEcCtD
Vemurafenib—Dermatitis—Amitriptyline—migraine	0.000501	0.00289	CcSEcCtD
Vemurafenib—Back pain—Valproic Acid—migraine	0.000501	0.00289	CcSEcCtD
Vemurafenib—Headache—Amitriptyline—migraine	0.000498	0.00288	CcSEcCtD
Vemurafenib—Eye disorder—Timolol—migraine	0.000495	0.00285	CcSEcCtD
Vemurafenib—Cardiac disorder—Timolol—migraine	0.000491	0.00283	CcSEcCtD
Vemurafenib—ABCG2—Fluoropyrimidine Activity—MTHFR—migraine	0.000487	0.00817	CbGpPWpGaD
Vemurafenib—Oedema peripheral—Gabapentin—migraine	0.000486	0.0028	CcSEcCtD
Vemurafenib—Connective tissue disorder—Gabapentin—migraine	0.000484	0.0028	CcSEcCtD
Vemurafenib—Angiopathy—Timolol—migraine	0.00048	0.00277	CcSEcCtD
Vemurafenib—Hypersensitivity—Propranolol—migraine	0.000477	0.00275	CcSEcCtD
Vemurafenib—Mediastinal disorder—Timolol—migraine	0.000477	0.00275	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Topiramate—migraine	0.000473	0.00273	CcSEcCtD
Vemurafenib—Nausea—Amitriptyline—migraine	0.000472	0.00273	CcSEcCtD
Vemurafenib—RAF1—Nongenotropic Androgen signaling—FOS—migraine	0.00047	0.00789	CbGpPWpGaD
Vemurafenib—Weight decreased—Topiramate—migraine	0.000469	0.0027	CcSEcCtD
Vemurafenib—Alopecia—Timolol—migraine	0.000468	0.0027	CcSEcCtD
Vemurafenib—Erythema multiforme—Gabapentin—migraine	0.000466	0.00269	CcSEcCtD
Vemurafenib—Asthenia—Propranolol—migraine	0.000465	0.00268	CcSEcCtD
Vemurafenib—Infestation—Topiramate—migraine	0.000462	0.00267	CcSEcCtD
Vemurafenib—Infestation NOS—Topiramate—migraine	0.000462	0.00267	CcSEcCtD
Vemurafenib—Erythema—Timolol—migraine	0.000461	0.00266	CcSEcCtD
Vemurafenib—Malnutrition—Timolol—migraine	0.000461	0.00266	CcSEcCtD
Vemurafenib—Eye disorder—Gabapentin—migraine	0.000461	0.00266	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Topiramate—migraine	0.000458	0.00264	CcSEcCtD
Vemurafenib—Cardiac disorder—Gabapentin—migraine	0.000457	0.00264	CcSEcCtD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—LRP1—migraine	0.000456	0.00765	CbGpPWpGaD
Vemurafenib—Neuropathy peripheral—Topiramate—migraine	0.000453	0.00261	CcSEcCtD
Vemurafenib—Cough—Valproic Acid—migraine	0.000452	0.00261	CcSEcCtD
Vemurafenib—Dysgeusia—Timolol—migraine	0.000451	0.0026	CcSEcCtD
Vemurafenib—Mediastinal disorder—Gabapentin—migraine	0.000444	0.00256	CcSEcCtD
Vemurafenib—Diarrhoea—Propranolol—migraine	0.000443	0.00256	CcSEcCtD
Vemurafenib—Chills—Gabapentin—migraine	0.000442	0.00255	CcSEcCtD
Vemurafenib—BRAF—Neuronal System—CACNA1A—migraine	0.000442	0.00742	CbGpPWpGaD
Vemurafenib—Myalgia—Valproic Acid—migraine	0.000441	0.00254	CcSEcCtD
Vemurafenib—Arthralgia—Valproic Acid—migraine	0.000441	0.00254	CcSEcCtD
Vemurafenib—Hypersensitivity—Verapamil—migraine	0.000439	0.00253	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000438	0.00253	CcSEcCtD
Vemurafenib—RAF1—Signaling of Hepatocyte Growth Factor Receptor—FOS—migraine	0.000437	0.00732	CbGpPWpGaD
Vemurafenib—RAF1—Trk receptor signaling mediated by the MAPK pathway—FOS—migraine	0.000437	0.00732	CbGpPWpGaD
Vemurafenib—Alopecia—Gabapentin—migraine	0.000436	0.00251	CcSEcCtD
Vemurafenib—Erythema—Gabapentin—migraine	0.000429	0.00248	CcSEcCtD
Vemurafenib—Malnutrition—Gabapentin—migraine	0.000429	0.00248	CcSEcCtD
Vemurafenib—Dizziness—Propranolol—migraine	0.000428	0.00247	CcSEcCtD
Vemurafenib—Asthenia—Verapamil—migraine	0.000427	0.00247	CcSEcCtD
Vemurafenib—Anaphylactic shock—Valproic Acid—migraine	0.000422	0.00244	CcSEcCtD
Vemurafenib—Pruritus—Verapamil—migraine	0.000421	0.00243	CcSEcCtD
Vemurafenib—RAF1—SHP2 signaling—BDNF—migraine	0.000421	0.00707	CbGpPWpGaD
Vemurafenib—Dysgeusia—Gabapentin—migraine	0.00042	0.00242	CcSEcCtD
Vemurafenib—Infection—Valproic Acid—migraine	0.00042	0.00242	CcSEcCtD
Vemurafenib—Back pain—Gabapentin—migraine	0.000415	0.0024	CcSEcCtD
Vemurafenib—Nervous system disorder—Valproic Acid—migraine	0.000414	0.00239	CcSEcCtD
Vemurafenib—Vomiting—Propranolol—migraine	0.000412	0.00238	CcSEcCtD
Vemurafenib—Skin disorder—Valproic Acid—migraine	0.00041	0.00237	CcSEcCtD
Vemurafenib—Oedema peripheral—Topiramate—migraine	0.000408	0.00236	CcSEcCtD
Vemurafenib—Rash—Propranolol—migraine	0.000408	0.00236	CcSEcCtD
Vemurafenib—RAF1—GMCSF-mediated signaling events—FOS—migraine	0.000408	0.00684	CbGpPWpGaD
Vemurafenib—Dermatitis—Propranolol—migraine	0.000408	0.00235	CcSEcCtD
Vemurafenib—Diarrhoea—Verapamil—migraine	0.000408	0.00235	CcSEcCtD
Vemurafenib—Connective tissue disorder—Topiramate—migraine	0.000407	0.00235	CcSEcCtD
Vemurafenib—Cough—Timolol—migraine	0.000402	0.00232	CcSEcCtD
Vemurafenib—RAF1—Transmission across Chemical Synapses—CACNA1A—migraine	0.000399	0.0067	CbGpPWpGaD
Vemurafenib—Hypotension—Valproic Acid—migraine	0.000395	0.00228	CcSEcCtD
Vemurafenib—Dizziness—Verapamil—migraine	0.000394	0.00227	CcSEcCtD
Vemurafenib—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000393	0.0066	CbGpPWpGaD
Vemurafenib—Myalgia—Timolol—migraine	0.000392	0.00226	CcSEcCtD
Vemurafenib—Arthralgia—Timolol—migraine	0.000392	0.00226	CcSEcCtD
Vemurafenib—Erythema multiforme—Topiramate—migraine	0.000392	0.00226	CcSEcCtD
Vemurafenib—RAF1—PDGF Pathway—FOS—migraine	0.000391	0.00656	CbGpPWpGaD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00039	0.00225	CcSEcCtD
Vemurafenib—Eye disorder—Topiramate—migraine	0.000387	0.00224	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Valproic Acid—migraine	0.000385	0.00222	CcSEcCtD
Vemurafenib—Cardiac disorder—Topiramate—migraine	0.000385	0.00222	CcSEcCtD
Vemurafenib—Nausea—Propranolol—migraine	0.000385	0.00222	CcSEcCtD
Vemurafenib—RAF1—IL-5 Signaling Pathway—FOS—migraine	0.000383	0.00643	CbGpPWpGaD
Vemurafenib—RAF1—Aryl Hydrocarbon Receptor—ESR1—migraine	0.00038	0.00638	CbGpPWpGaD
Vemurafenib—Vomiting—Verapamil—migraine	0.000379	0.00219	CcSEcCtD
Vemurafenib—Angiopathy—Topiramate—migraine	0.000376	0.00217	CcSEcCtD
Vemurafenib—Anaphylactic shock—Timolol—migraine	0.000376	0.00217	CcSEcCtD
Vemurafenib—RAF1—ErbB2/ErbB3 signaling events—FOS—migraine	0.000376	0.00631	CbGpPWpGaD
Vemurafenib—Rash—Verapamil—migraine	0.000376	0.00217	CcSEcCtD
Vemurafenib—RAF1—Axon guidance—SCN1A—migraine	0.000375	0.0063	CbGpPWpGaD
Vemurafenib—Dermatitis—Verapamil—migraine	0.000375	0.00217	CcSEcCtD
Vemurafenib—Cough—Gabapentin—migraine	0.000374	0.00216	CcSEcCtD
Vemurafenib—Mediastinal disorder—Topiramate—migraine	0.000374	0.00216	CcSEcCtD
Vemurafenib—Infection—Timolol—migraine	0.000374	0.00216	CcSEcCtD
Vemurafenib—Headache—Verapamil—migraine	0.000373	0.00215	CcSEcCtD
Vemurafenib—Chills—Topiramate—migraine	0.000372	0.00215	CcSEcCtD
Vemurafenib—BRAF—TSH signaling pathway—FOS—migraine	0.000371	0.00623	CbGpPWpGaD
Vemurafenib—BRAF—Downstream signaling in naïve CD8+ T cells—FOS—migraine	0.000371	0.00623	CbGpPWpGaD
Vemurafenib—Nervous system disorder—Timolol—migraine	0.000369	0.00213	CcSEcCtD
Vemurafenib—RAF1—IL-2 Signaling Pathway—FOS—migraine	0.000369	0.00618	CbGpPWpGaD
Vemurafenib—Decreased appetite—Valproic Acid—migraine	0.000367	0.00212	CcSEcCtD
Vemurafenib—Alopecia—Topiramate—migraine	0.000366	0.00211	CcSEcCtD
Vemurafenib—Myalgia—Gabapentin—migraine	0.000365	0.00211	CcSEcCtD
Vemurafenib—Arthralgia—Gabapentin—migraine	0.000365	0.00211	CcSEcCtD
Vemurafenib—Skin disorder—Timolol—migraine	0.000365	0.00211	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Valproic Acid—migraine	0.000365	0.0021	CcSEcCtD
Vemurafenib—Fatigue—Valproic Acid—migraine	0.000364	0.0021	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000363	0.00209	CcSEcCtD
Vemurafenib—RAF1—FCERI mediated MAPK activation—FOS—migraine	0.000362	0.00607	CbGpPWpGaD
Vemurafenib—Constipation—Valproic Acid—migraine	0.000361	0.00208	CcSEcCtD
Vemurafenib—Malnutrition—Topiramate—migraine	0.000361	0.00208	CcSEcCtD
Vemurafenib—Erythema—Topiramate—migraine	0.000361	0.00208	CcSEcCtD
Vemurafenib—Nausea—Verapamil—migraine	0.000354	0.00204	CcSEcCtD
Vemurafenib—Dysgeusia—Topiramate—migraine	0.000353	0.00204	CcSEcCtD
Vemurafenib—Hypotension—Timolol—migraine	0.000351	0.00203	CcSEcCtD
Vemurafenib—Anaphylactic shock—Gabapentin—migraine	0.00035	0.00202	CcSEcCtD
Vemurafenib—Back pain—Topiramate—migraine	0.000349	0.00202	CcSEcCtD
Vemurafenib—Infection—Gabapentin—migraine	0.000348	0.00201	CcSEcCtD
Vemurafenib—Nervous system disorder—Gabapentin—migraine	0.000343	0.00198	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Timolol—migraine	0.000343	0.00198	CcSEcCtD
Vemurafenib—Skin disorder—Gabapentin—migraine	0.00034	0.00196	CcSEcCtD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000336	0.00563	CbGpPWpGaD
Vemurafenib—Body temperature increased—Valproic Acid—migraine	0.000334	0.00193	CcSEcCtD
Vemurafenib—Hypotension—Gabapentin—migraine	0.000327	0.00189	CcSEcCtD
Vemurafenib—Decreased appetite—Timolol—migraine	0.000327	0.00189	CcSEcCtD
Vemurafenib—RAF1—IL-3 Signaling Pathway—FOS—migraine	0.000326	0.00547	CbGpPWpGaD
Vemurafenib—Gastrointestinal disorder—Timolol—migraine	0.000325	0.00187	CcSEcCtD
Vemurafenib—Fatigue—Timolol—migraine	0.000324	0.00187	CcSEcCtD
Vemurafenib—RAF1—Axon guidance—SCN2A—migraine	0.000319	0.00535	CbGpPWpGaD
Vemurafenib—Musculoskeletal discomfort—Gabapentin—migraine	0.000319	0.00184	CcSEcCtD
Vemurafenib—Cough—Topiramate—migraine	0.000315	0.00182	CcSEcCtD
Vemurafenib—Hypersensitivity—Valproic Acid—migraine	0.000311	0.0018	CcSEcCtD
Vemurafenib—Arthralgia—Topiramate—migraine	0.000307	0.00177	CcSEcCtD
Vemurafenib—Myalgia—Topiramate—migraine	0.000307	0.00177	CcSEcCtD
Vemurafenib—RAF1—Neuronal System—CACNA1A—migraine	0.000306	0.00513	CbGpPWpGaD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000305	0.00176	CcSEcCtD
Vemurafenib—Decreased appetite—Gabapentin—migraine	0.000304	0.00176	CcSEcCtD
Vemurafenib—Asthenia—Valproic Acid—migraine	0.000303	0.00175	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Gabapentin—migraine	0.000302	0.00174	CcSEcCtD
Vemurafenib—Fatigue—Gabapentin—migraine	0.000302	0.00174	CcSEcCtD
Vemurafenib—RAF1—IL2-mediated signaling events—FOS—migraine	0.000301	0.00506	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—TRPM8—migraine	0.0003	0.00504	CbGpPWpGaD
Vemurafenib—Constipation—Gabapentin—migraine	0.000299	0.00173	CcSEcCtD
Vemurafenib—Pruritus—Valproic Acid—migraine	0.000299	0.00172	CcSEcCtD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—TRPM8—migraine	0.000297	0.00499	CbGpPWpGaD
Vemurafenib—Body temperature increased—Timolol—migraine	0.000297	0.00172	CcSEcCtD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000294	0.00494	CbGpPWpGaD
Vemurafenib—Infection—Topiramate—migraine	0.000293	0.00169	CcSEcCtD
Vemurafenib—Diarrhoea—Valproic Acid—migraine	0.000289	0.00167	CcSEcCtD
Vemurafenib—Nervous system disorder—Topiramate—migraine	0.000289	0.00167	CcSEcCtD
Vemurafenib—Skin disorder—Topiramate—migraine	0.000286	0.00165	CcSEcCtD
Vemurafenib—BRAF—Corticotropin-releasing hormone—FOS—migraine	0.000285	0.00477	CbGpPWpGaD
Vemurafenib—RAF1—Kit receptor signaling pathway—FOS—migraine	0.000281	0.00471	CbGpPWpGaD
Vemurafenib—Dizziness—Valproic Acid—migraine	0.000279	0.00161	CcSEcCtD
Vemurafenib—Hypersensitivity—Timolol—migraine	0.000277	0.0016	CcSEcCtD
Vemurafenib—Body temperature increased—Gabapentin—migraine	0.000277	0.0016	CcSEcCtD
Vemurafenib—Hypotension—Topiramate—migraine	0.000275	0.00159	CcSEcCtD
Vemurafenib—RAF1—Signaling by ERBB4—PGR—migraine	0.000274	0.00459	CbGpPWpGaD
Vemurafenib—RAF1—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.000273	0.00459	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—TGFBR2—migraine	0.00027	0.00453	CbGpPWpGaD
Vemurafenib—Asthenia—Timolol—migraine	0.00027	0.00156	CcSEcCtD
Vemurafenib—Vomiting—Valproic Acid—migraine	0.000269	0.00155	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Topiramate—migraine	0.000268	0.00155	CcSEcCtD
Vemurafenib—RAF1—Developmental Biology—SCN1A—migraine	0.000268	0.00449	CbGpPWpGaD
Vemurafenib—RAF1—Endothelins—FOS—migraine	0.000267	0.00447	CbGpPWpGaD
Vemurafenib—Rash—Valproic Acid—migraine	0.000266	0.00154	CcSEcCtD
Vemurafenib—Dermatitis—Valproic Acid—migraine	0.000266	0.00154	CcSEcCtD
Vemurafenib—Pruritus—Timolol—migraine	0.000266	0.00154	CcSEcCtD
Vemurafenib—Headache—Valproic Acid—migraine	0.000265	0.00153	CcSEcCtD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—TRPM8—migraine	0.000262	0.00439	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—BDNF—migraine	0.00026	0.00436	CbGpPWpGaD
Vemurafenib—RAF1—Oncostatin M Signaling Pathway—FOS—migraine	0.00026	0.00436	CbGpPWpGaD
Vemurafenib—Hypersensitivity—Gabapentin—migraine	0.000258	0.00149	CcSEcCtD
Vemurafenib—Diarrhoea—Timolol—migraine	0.000257	0.00148	CcSEcCtD
Vemurafenib—RAF1—Leptin signaling pathway—ESR1—migraine	0.000257	0.00432	CbGpPWpGaD
Vemurafenib—RAF1—TSH signaling pathway—FOS—migraine	0.000257	0.00431	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—FOS—migraine	0.000257	0.00431	CbGpPWpGaD
Vemurafenib—Decreased appetite—Topiramate—migraine	0.000256	0.00148	CcSEcCtD
Vemurafenib—BRAF—ErbB1 downstream signaling—FOS—migraine	0.000256	0.00429	CbGpPWpGaD
Vemurafenib—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000255	0.00427	CbGpPWpGaD
Vemurafenib—Gastrointestinal disorder—Topiramate—migraine	0.000254	0.00147	CcSEcCtD
Vemurafenib—Fatigue—Topiramate—migraine	0.000254	0.00147	CcSEcCtD
Vemurafenib—RAF1—BCR signaling pathway—FOS—migraine	0.000254	0.00426	CbGpPWpGaD
Vemurafenib—Constipation—Topiramate—migraine	0.000252	0.00145	CcSEcCtD
Vemurafenib—Asthenia—Gabapentin—migraine	0.000251	0.00145	CcSEcCtD
Vemurafenib—Nausea—Valproic Acid—migraine	0.000251	0.00145	CcSEcCtD
Vemurafenib—Dizziness—Timolol—migraine	0.000249	0.00144	CcSEcCtD
Vemurafenib—Pruritus—Gabapentin—migraine	0.000248	0.00143	CcSEcCtD
Vemurafenib—Diarrhoea—Gabapentin—migraine	0.00024	0.00138	CcSEcCtD
Vemurafenib—Vomiting—Timolol—migraine	0.000239	0.00138	CcSEcCtD
Vemurafenib—Rash—Timolol—migraine	0.000237	0.00137	CcSEcCtD
Vemurafenib—Dermatitis—Timolol—migraine	0.000237	0.00137	CcSEcCtD
Vemurafenib—Headache—Timolol—migraine	0.000236	0.00136	CcSEcCtD
Vemurafenib—Body temperature increased—Topiramate—migraine	0.000233	0.00134	CcSEcCtD
Vemurafenib—Dizziness—Gabapentin—migraine	0.000232	0.00134	CcSEcCtD
Vemurafenib—RAF1—Developmental Biology—SCN2A—migraine	0.000228	0.00382	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000227	0.00382	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000227	0.00382	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—TGFBR2—migraine	0.000227	0.0038	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ATP1A2—migraine	0.000225	0.00378	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ATP1A3—migraine	0.000225	0.00378	CbGpPWpGaD
Vemurafenib—ABCG2—HIF-1-alpha transcription factor network—FOS—migraine	0.000224	0.00376	CbGpPWpGaD
Vemurafenib—Nausea—Timolol—migraine	0.000223	0.00129	CcSEcCtD
Vemurafenib—BRAF—PDGFR-beta signaling pathway—FOS—migraine	0.000223	0.00374	CbGpPWpGaD
Vemurafenib—Vomiting—Gabapentin—migraine	0.000223	0.00128	CcSEcCtD
Vemurafenib—Rash—Gabapentin—migraine	0.000221	0.00127	CcSEcCtD
Vemurafenib—Dermatitis—Gabapentin—migraine	0.000221	0.00127	CcSEcCtD
Vemurafenib—Headache—Gabapentin—migraine	0.000219	0.00127	CcSEcCtD
Vemurafenib—Hypersensitivity—Topiramate—migraine	0.000217	0.00125	CcSEcCtD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—ESR1—migraine	0.000212	0.00356	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—MTHFR—migraine	0.000212	0.00356	CbGpPWpGaD
Vemurafenib—Asthenia—Topiramate—migraine	0.000211	0.00122	CcSEcCtD
Vemurafenib—Pruritus—Topiramate—migraine	0.000208	0.0012	CcSEcCtD
Vemurafenib—RAF1—Developmental Biology—MEF2D—migraine	0.000208	0.00349	CbGpPWpGaD
Vemurafenib—Nausea—Gabapentin—migraine	0.000208	0.0012	CcSEcCtD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000207	0.00348	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000207	0.00348	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—BDNF—migraine	0.000204	0.00341	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000203	0.00341	CbGpPWpGaD
Vemurafenib—Diarrhoea—Topiramate—migraine	0.000202	0.00116	CcSEcCtD
Vemurafenib—RAF1—TCR Signaling Pathway—FOS—migraine	0.0002	0.00336	CbGpPWpGaD
Vemurafenib—BRAF—Downstream signaling in naïve CD8+ T cells—TNF—migraine	0.0002	0.00335	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000198	0.00333	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000198	0.00333	CbGpPWpGaD
Vemurafenib—RAF1—TWEAK Signaling Pathway—TNF—migraine	0.000198	0.00332	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000198	0.00332	CbGpPWpGaD
Vemurafenib—RAF1—Corticotropin-releasing hormone—FOS—migraine	0.000197	0.0033	CbGpPWpGaD
Vemurafenib—Dizziness—Topiramate—migraine	0.000195	0.00112	CcSEcCtD
Vemurafenib—RAF1—Transmembrane transport of small molecules—HTR3A—migraine	0.000193	0.00324	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—HTR3A—migraine	0.000192	0.00322	CbGpPWpGaD
Vemurafenib—Vomiting—Topiramate—migraine	0.000187	0.00108	CcSEcCtD
Vemurafenib—RAF1—MAPK Signaling Pathway—TGFBR2—migraine	0.000187	0.00314	CbGpPWpGaD
Vemurafenib—Rash—Topiramate—migraine	0.000186	0.00107	CcSEcCtD
Vemurafenib—Dermatitis—Topiramate—migraine	0.000186	0.00107	CcSEcCtD
Vemurafenib—Headache—Topiramate—migraine	0.000185	0.00107	CcSEcCtD
Vemurafenib—RAF1—Aryl Hydrocarbon Receptor—TNF—migraine	0.000184	0.00309	CbGpPWpGaD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—FOS—migraine	0.000181	0.00304	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—BDNF—migraine	0.00018	0.00302	CbGpPWpGaD
Vemurafenib—RAF1—Ceramide signaling pathway—TNF—migraine	0.000178	0.00299	CbGpPWpGaD
Vemurafenib—RAF1—ErbB1 downstream signaling—FOS—migraine	0.000177	0.00297	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—FOS—migraine	0.000176	0.00295	CbGpPWpGaD
Vemurafenib—Nausea—Topiramate—migraine	0.000175	0.00101	CcSEcCtD
Vemurafenib—ALB—Folate Metabolism—MTHFR—migraine	0.000173	0.00289	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—HTR3A—migraine	0.000169	0.00283	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000162	0.00272	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—TRPM8—migraine	0.000162	0.00271	CbGpPWpGaD
Vemurafenib—RAF1—Cardiac Hypertrophic Response—TNF—migraine	0.00016	0.00268	CbGpPWpGaD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—FOS—migraine	0.000154	0.00258	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—FOS—migraine	0.000147	0.00247	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—ESR1—migraine	0.000146	0.00245	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—RAMP1—migraine	0.000144	0.00241	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CALCRL—migraine	0.000144	0.00241	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000143	0.0024	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling in naïve CD8+ T cells—TNF—migraine	0.000138	0.00232	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—FOS—migraine	0.000138	0.00231	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—MTHFR—migraine	0.000137	0.0023	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—FOS—migraine	0.000126	0.00212	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—FOS—migraine	0.000125	0.0021	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000125	0.00209	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RAMP1—migraine	0.000123	0.00206	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CALCRL—migraine	0.000123	0.00206	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	0.000122	0.00205	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	0.000122	0.00205	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000122	0.00204	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—FOS—migraine	0.000122	0.00204	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000117	0.00196	CbGpPWpGaD
Vemurafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000114	0.00191	CbGpPWpGaD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—TNF—migraine	0.000106	0.00178	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR1D—migraine	0.000105	0.00175	CbGpPWpGaD
Vemurafenib—BRAF—Disease—LRP1—migraine	0.000104	0.00175	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—HTR3A—migraine	0.000104	0.00175	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR2B—migraine	9.72e-05	0.00163	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—TNF—migraine	9.45e-05	0.00159	CbGpPWpGaD
Vemurafenib—ALB—Vitamin B12 Metabolism—TNF—migraine	9.13e-05	0.00153	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR1D—migraine	8.92e-05	0.0015	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CALCRL—migraine	8.5e-05	0.00143	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RAMP1—migraine	8.5e-05	0.00143	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR2B—migraine	8.3e-05	0.00139	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CACNA1A—migraine	7.63e-05	0.00128	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TNF—migraine	7.43e-05	0.00125	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—LRP1—migraine	7.3e-05	0.00123	CbGpPWpGaD
Vemurafenib—RAF1—Disease—LRP1—migraine	7.22e-05	0.00121	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—LRP1—migraine	7.15e-05	0.0012	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	6.94e-05	0.00116	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	6.94e-05	0.00116	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CALCA—migraine	6.72e-05	0.00113	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CACNA1A—migraine	6.72e-05	0.00113	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TNF—migraine	6.54e-05	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR1B—migraine	6.33e-05	0.00106	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR1D—migraine	6.17e-05	0.00104	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR1A—migraine	6.1e-05	0.00102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—TAC1—migraine	6e-05	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—NPS—migraine	6e-05	0.00101	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—TNF—migraine	5.9e-05	0.00099	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—migraine	5.9e-05	0.00099	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR2C—migraine	5.89e-05	0.000988	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR2B—migraine	5.74e-05	0.000963	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—EDNRA—migraine	5.73e-05	0.000961	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NOTCH4—migraine	5.6e-05	0.00094	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CALCA—migraine	5.51e-05	0.000925	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TGFBR2—migraine	5.41e-05	0.000908	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR1B—migraine	5.41e-05	0.000907	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR1A—migraine	5.2e-05	0.000873	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR7—migraine	5.16e-05	0.000865	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TAC1—migraine	5.13e-05	0.00086	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PGR—migraine	5.13e-05	0.00086	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NPS—migraine	5.13e-05	0.00086	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—LRP1—migraine	5.05e-05	0.000848	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR2C—migraine	5.03e-05	0.000843	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EDNRA—migraine	4.89e-05	0.00082	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NOTCH3—migraine	4.76e-05	0.000799	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CALCA—migraine	4.71e-05	0.00079	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CALCA—migraine	4.65e-05	0.00078	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CALCA—migraine	4.61e-05	0.000773	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—FOS—migraine	4.53e-05	0.00076	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR7—migraine	4.4e-05	0.000739	CbGpPWpGaD
Vemurafenib—BRAF—Disease—MTHFR—migraine	4.4e-05	0.000738	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CACNA1A—migraine	4.15e-05	0.000695	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOTCH4—migraine	3.88e-05	0.00065	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TGFBR2—migraine	3.79e-05	0.000636	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TGFBR2—migraine	3.75e-05	0.000628	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR1B—migraine	3.74e-05	0.000628	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TGFBR2—migraine	3.71e-05	0.000623	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR2A—migraine	3.61e-05	0.000606	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR1A—migraine	3.6e-05	0.000604	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PGR—migraine	3.55e-05	0.000595	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TAC1—migraine	3.55e-05	0.000595	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NPS—migraine	3.55e-05	0.000595	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR2C—migraine	3.48e-05	0.000583	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CACNA1A—migraine	3.42e-05	0.000574	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EDNRA—migraine	3.38e-05	0.000568	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOTCH3—migraine	3.3e-05	0.000553	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CALCA—migraine	3.26e-05	0.000546	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR2A—migraine	3.08e-05	0.000517	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR7—migraine	3.05e-05	0.000511	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MTHFR—migraine	3.04e-05	0.00051	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MTHFR—migraine	3.02e-05	0.000506	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CACNA1A—migraine	2.9e-05	0.000486	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—migraine	2.76e-05	0.000463	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ESR1—migraine	2.74e-05	0.000459	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—FOS—migraine	2.64e-05	0.000443	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TGFBR2—migraine	2.62e-05	0.00044	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—MTHFR—migraine	2.53e-05	0.000424	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CACNA1A—migraine	2.24e-05	0.000375	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—MTHFR—migraine	2.22e-05	0.000373	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR2A—migraine	2.13e-05	0.000358	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ESR1—migraine	1.89e-05	0.000318	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—MTHFR—migraine	1.37e-05	0.00023	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—MTHFR—migraine	1.13e-05	0.00019	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—MTHFR—migraine	9.59e-06	0.000161	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MTHFR—migraine	7.4e-06	0.000124	CbGpPWpGaD
